Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Trial compares 1% Terbinafine vs 1% Clotrimazole C...
A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...
3 min
Study reveals the effect of Isotretinoin on menstr...
Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...
1 min
Paracetamol vs Ibuprofen. Which is better for trea...
In a systematic review and meta-analysis, both Paracetamol and Ibuprofen demonstrated superior effectiveness compared to a placebo in addressing...
3 min
Study assesses efficacy of ketorolac for treatment...
In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...
3 min
Tirzepatide injection gets FDA approval for chroni...
According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...
4 min
Is alcohol safe for rheumatoid arthritis patients...
Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...
2 min
Does exercise induce GERD or relieve acid reflux?...
Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...
3 min
GERD Symptoms: Could Intermittent Fasting Help?
A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...
2 min
Microneedling + minoxidil boosts hair regrowth in...
In a systematic review and meta-analysis, combining microneedling with minoxidil offered markedly better outcomes for individuals with androgenet...
1 min
Understanding bleeding patterns associated with ea...
A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...
2 min
Semaglutide and tirzepatide redefine treatment goals in MASLD
Semaglutide and tirzepatide reshape the treatment landscape of MASLD by coupling histologic liver improvement with proven cardiometabolic protect...
Scientists uncover gut–metabolism connection in children with con...
Gut microbiota dysbiosis and altered amino acid metabolism are associated with constipation in children with allergic rhinitis, highlighting Hung...
Researchers uncover genetic signature behind recurrent vulvovagin...
Inherited variations in the TLR4 immune signaling pathway are emerging as important determinants of recurrent vulvovaginal candidiasis risk, high...
New research shows dual therapy rivals bismuth quadruple regimen...
A comprehensive meta-analysis found that 14-day tegoprazan–amoxicillin dual therapy achieved H. pylori eradication rates comparable to BQT,...
Loxoprofen shows comparable low back pain relief with 97% favorab...
Loxoprofen (60 mg three times daily) demonstrates comparable efficacy to diclofenac (50 mg three times daily) for acute low back pain while showi...
How sleep disturbances affect patients with diabetes and chronic...
Sleep disturbances are linked to poorer kidney, cardiovascular, metabolic, and psychological outcomes in people living with both diabetes and chr...
Tapinarof 1% cream gains strong guideline support for children wi...
The 2026 AAD guidelines strongly recommend tapinarof 1% cream for children aged ≥2 years with atopic dermatitis. It is the only steroid-free t...
Etripamil nasal spray receives FDA approval for rapid relief of P...
FDA has approved intranasal etripamil for paroxysmal supraventricular tachycardia, delivering fast, on-demand restoration of normal heart rhythm....
FDA clears new oral therapy rilzabrutinib for treatment-resistant...
FDA approves rilzabrutinib tablets as a new oral treatment option for adults with persistent or chronic ITP who show insufficient response to sta...
FDA expands access to omalizumab therapy with first interchangeab...
The FDA has authorized omalizumab-igec as the first interchangeable biosimilar to omalizumab for treating asthma, urticaria, chronic rhinosinusit...
FDA introduces front-of-package nutrition labels to tackle chroni...
The FDA has proposed requisition of front-of-package nutrition labels on most packaged foods to clearly display levels of saturated fat, sodium,...
EMA issues flu vaccine composition guidance for 2025/2026 season
EMA recommends updated trivalent influenza vaccines for the 2025/2026 season, selecting strains based on global surveillance data and excluding B...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.